The authors supported their conclusions by analysis of SETD7 expression in the GSE39582 dataset (443 CRC samples) using the Syntarget tool (bioprofiling.de) to show that high co-expression of SETD7 and KHDRBS1 (Sam68) significantly correlated with better overall survival of CRC patients, while patients with low SETD7 and high KHDRBS1 expression showed poor OS. Here, KHDRBS1 is linked to colorectal carcinoma.